FOLD Stock Risk & Deep Value Analysis

Amicus Therapeutics, Inc.

Healthcare • Biotechnology

DVR Score

7.9

out of 10

Solid Pick

The Bottom Line on FOLD

We analyzed Amicus Therapeutics, Inc. using our deep value framework. Sign in to see our full verdict and DVR Score.

We ran FOLD through our deep value framework — analyzing financial health, distress signals, competitive moat, and risk factors. Here's what we found.

Updated Oct 5, 2025•Run Fresh Analysis →

About Amicus Therapeutics, Inc. (FOLD)

Sector

Healthcare

Industry

Biotechnology

Market Cap Category

mid

Market Cap

$2.53B

FOLD Deep Value Analysis

Amicus (FOLD) targets multi-billion dollar rare disease markets with approved, differentiated therapies like Galafold (Fabry) and the newly launched AT-GAA (Pompe). AT-GAA's unique mechanism offers a significant competitive edge, driving a clear path to substantial market share if commercial execution is strong. Experienced leadership and multiple catalysts, notably AT-GAA's ramp-up, support growth. The primary risk is financial sustainability; despite a decent cash runway, achieving projected profitability by 2026 is entirely dependent on AT-GAA's rapid market adoption to avoid future dilution. This execution risk tempers an otherwise compelling long-term potential.

FOLD Financial Health Metrics

Market Cap

$2.53B

📊 Explore More Stock Analysis

Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential.

Analyze Any Stock →View Top 100 Deep Value Stocks →

Important Disclaimer – Not Financial Advice

Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.

All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research and consult with a qualified financial advisor.

More Resources to Boost Your Portfolio

Explore our other guides and tools to maximize your investment returns